SOLV
Solventum
Surgical & Medical Instruments & Apparatus · Health Care
$84.76+0.01%
Quote via Yahoo Finance, may be delayed · 2026-11-03 · 4:00 PM ET
Daily prices: Yahoo Finance, split-adjusted. As of 2026-11-03.
Drag across the line to read a price. Dots mark earnings, filings and dividends.
Weak profile
Price vs model range lifts this profile the most.
As of 2025-12-31. Latest quarter ended 2026-06-30. v1 methodology, subject to change.
No prior quarter is available in this sample.
Sector rank 37 of 46
In plain English
- Solventum operates in Surgical & Medical Instruments & Apparatus.
- Latest-year revenue was 8.3 billion.
- The profile score is 44, a Weak profile. Price is the strongest listed input.
Written from the figures on this page. No language model was called. It may still be wrong. Not advice.
As of 2025-12-31. Latest quarter ended 2026-06-30. SEC EDGAR companyfacts, fetched 2026-11-01. SEC filing
Financials
Tap a column to read the value.
P/E vs own history
Now 10.4 times, 5-year median 9.4 times.
Line is the quarterly multiple. The band is the 25th to 75th percentile of that history. The dashed line is the median.
Earnings
Actual earnings per share from EDGAR filings. Historical estimates are not used.
Actual from EDGAR
Data confidence
The Company Score summarises financial characteristics relative to similar companies using a published formula. It does not predict future returns.
SEC EDGAR companyfacts, fetched 2026-11-01.